Silibinin Inhibits Adipogenesis and Induces Apoptosis in 3T3-L1 Adipocytes
Silibinin Inhibits Adipogenesis and Induces Apoptosis in 3T3-L1 Adipocytes
复制标题
DOI:
10.4014/mbl.1610.10005
复制
发表时间:
2017-03-01
影响因子:
--
通讯作者:
Nam, Ju-Ock
中科院分区:
文献类型:
--
作者:
Lee, Seul Gi;Kwon, Taeg Kyu;Nam, Ju-Ock
C/EBP beta and C/EBPd are required for the initiation of adipogenesis and induce the expression of key adipogenic regulators, such as PPAR. and C/EBPa. In the present study, we have examined the effects of silibinin and its possible molecular mechanisms in regulating adipocyte differentiation and expression of C/EBP beta and C/EBPd in the early stage of adipogenesis. Silibinin statistically significantly inhibits intracellular lipid accumulation and the mRNA expression of various genes involved at different stages during adipogenesis. Silibinin also suppresses expression of lipoprotein lipase (LPL), fatty acid binding protein 4 (AP2), and adiponectin in 3T3-L1 adipocytes. Thus, the anti-adipogenic effect of silibinin seems to originate from the ability to inhibit the expression of C/EBP beta and C/EBPd. Furthermore, silibinin decreases cell viability for differentiation period and induces apoptotic cell death through capspase-3 activation.